Filter
5401
Filtered Results: 5401
Text search:
drug
access
Featured
Recommendations
469
New Publications
1437
Language
Document type
No document type
3364
Studies & Reports
824
Guidelines
635
Manuals
220
Strategic & Response Plan
157
Fact sheets
78
Training Material
60
Situation Updates
27
Infographics
17
Resource Platforms
9
Brochures
5
Online Courses
3
App
2
Countries / Regions
India
301
Global
170
Kenya
166
South Africa
140
Uganda
126
Ethiopia
122
Western and Central Europe
121
Nigeria
113
Nepal
93
Tanzania
90
Liberia
88
Sierra Leone
87
Malawi
86
Africa
81
Zambia
80
Myanmar / Burma
77
Latin America and the Carribbean
69
Bangladesh
69
Ghana
66
Rwanda
66
Eastern Europe
65
Ukraine
59
Philippines
47
Namibia
46
Zimbabwe
45
Asia
43
Cambodia
37
Lesotho
36
South–East Asia Region
35
Russia
33
Syria
29
Congo, Democratic Republic of
27
Senegal
26
Botswana
26
Indonesia
26
Mozambique
24
Burkina Faso
21
Colombia
19
Middle East and North Africa
19
East and Southern Africa
19
Brazil
19
South Sudan
19
Eswatini/ Swaziland
19
West and Central Africa
17
Cameroon
16
Tajikistan
14
Haiti
14
Albania
13
USA
13
Venezuela
13
Eastern Europe and Central Asia
13
Germany
12
Thailand
11
Guinea
11
Argentina
11
Vietnam
10
Georgia
10
Pakistan
10
Benin
9
Afghanistan
9
Moldova
9
China
8
Peru
8
Sudan
8
Yemen
8
Laos
7
Armenia
7
Paraguay
7
North Macedonia
6
Mexico
6
El Salvador
6
Western Pacific Region
6
Chile
5
Jordan
5
Lebanon
5
Sri Lanka
5
Central African Republic
5
Iraq
5
Turkey
4
Jamaica
4
United Kingdom
4
Southern Africa
4
Bolivia
4
Mali
4
Libya
4
Somalia
4
Timor Leste/ East Timor
3
Iran
3
Kyrgyzstan
3
North America
3
Spain
3
Côte d’Ivoire / Ivory Coast
3
Papua New Guinea
3
Palestine
3
Angola
3
Bhutan
3
Madagascar
3
Serbia
2
Kazakhstan
2
Canada
2
Fiji
2
Estonia
2
Uzbekistan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
Gabon
2
Uruguay
2
France
2
Portugal
2
Belarus
2
Romania
2
Poland
2
Honduras
2
North Korea
1
Switzerland
1
Australia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Malaysia
1
Mongolia
1
Qatar
1
Bulgaria
1
Italy
1
Lithuania
1
Ireland
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Nicaragua
1
Egypt
1
Greece
1
Chad
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2063
Clinical Guidelines
461
Public Health
260
Women & Child Health
211
Key Resources
107
Capacity Building
80
Pharmacy & Technologies
57
Annual Report MEDBOX
1
Toolboxes
HIV
707
TB
539
Mental Health
530
AMR
268
COVID-19
234
Pharmacy
161
NTDs
161
NCDs
106
Caregiver
103
Rapid Response
84
Ebola
81
Planetary Health
73
Refugee
71
Conflict
65
Disability
62
Global Health Education
57
Health Financing Toolbox
37
Natural Hazards
19
Polio
19
Cholera
18
Social Ethics
16
Zika
16
Specific Hazards
14
European Scientific Journal, November edition vol. 8, No.26 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431
Accessed: 29.09.2019
International Journal of Infectious Diseases 32 (2015) 170–178
http://dx.doi.org/10.1016/j.ijid.2014.11.023
1201-9712/ß 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http:...
Original Research
African Journal of Primary Health Care & Family Medicine
ISSN: (Online) 2071-2936, (Print) 2071-2928
Open Access
The report shows that where people and communities living with and affected by HIV are engaged in decision-making and HIV service delivery, new infections decline and more people living with HIV gain access to treatment. When people have the power to choose, to know, to thrive, to demand and to work...
Ade et al. BMC Health Services Research (2016) 16:5
Background: In the “Centre National Hospitalier de Pneumo-Phtisiologie” of Cotonou, Benin, little is known about
the characteristics of patients who have not attended their scheduled appointment, the results of tracing and the
possible b...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
Senegal has adopted the World Health Organization–Joint United Nations Programme on HIV/AIDS recommended 90-90-90 targets.5 The adoption of this strategy means that the country is expected, by 2020, to have 90% of its population living with HIV diagnosed, 90% of all those diagnosed receiving susta...
HIV infection, due to the immunosuppressant that leads, nowadays constitutes an aggravating factor of endemic tuberculosis. Tuberculosis remains a huge burden to human health, even in the early 21st century. The situation is deteriorating in many countries, particularly because of the synergy with t...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
There are indigenous communities at high risk in every country of the region. At stake are the lives of 45 million people who belong to more than 800 indigenous peoples. Of these, some 100 are spread across several countries, around 200 maintain voluntary isolation or are in initial contact, and nea...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
